Current progress in antiviral strategies

Z Lou, Y Sun, Z Rao - Trends in pharmacological sciences, 2014 - cell.com
The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus
(HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new …

A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities

SM Mousavi, M Zarei, SA Hashemi… - Artificial cells …, 2019 - Taylor & Francis
Rhodanines are accepted as advantaged heterocycles in medicinal chemistry as one of the
4-thiazolidinones subtypes. The aim of this paper is to analyze the features of rhodanine and …

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation

T Tomašić, L Peterlin Mašič - Expert opinion on drug discovery, 2012 - Taylor & Francis
Introduction: Rhodanine-based compounds have been associated with numerous biological
activities. After many years of research in drug discovery, they have gained a reputation as …

Entry inhibitors: efficient means to block viral infection

GP Pattnaik, H Chakraborty - The Journal of Membrane Biology, 2020 - Springer
The emerging and re-emerging viral infections are constant threats to human health and
wellbeing. Several strategies have been explored to develop vaccines against these viral …

The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes

S Bayindir, C Caglayan, M Karaman, İ Gülcin - Bioorganic Chemistry, 2019 - Elsevier
Recently, inhibition effects of enzymes such as acetylcholinesterase (AChE) and carbonic
anhydrase (CA) has appeared as a promising approach for pharmacological intervention in …

2-Activated 1, 3-enynes in enantioselective synthesis

X Bao, J Ren, Y Yang, X Ye, B Wang… - Organic & Biomolecular …, 2020 - pubs.rsc.org
The rapid enantioselective synthesis of valuable building blocks and pharmaceutically
important compounds from easily accessible precursors is one of the major areas of focus in …

Inhibition of HIV-1 by fusion inhibitors

D Eggink, B Berkhout… - Current pharmaceutical …, 2010 - ingentaconnect.com
The envelope glycoprotein complex (Env) is responsible for entry of the human
immunodeficiency virus type 1 (HIV-1) into cells by mediating attachment to target cells and …

From laptop to benchtop to bedside: structure-based drug design on protein targets

L Chen, JK Morrow, HT Tran… - Current …, 2012 - ingentaconnect.com
As an important aspect of computer-aided drug design, structure-based drug design brought
a new horizon to pharmaceutical development. This in silico method permeates all aspects …

Design and synthesis of 5-(substituted benzylidene) thiazolidine-2, 4-dione derivatives as novel tyrosinase inhibitors

YM Ha, YJ Park, JA Kim, D Park, JY Park… - European journal of …, 2012 - Elsevier
In continuing our search for novel tyrosinase inhibitors, a series of 5-(substituted
benzylidene) thiazolidine-2, 4-diones were rationally designed and synthesized, and their …

Is there a future for antiviral fusion inhibitors?

B Berkhout, D Eggink, RW Sanders - Current opinion in virology, 2012 - Elsevier
Entry of human immunodeficiency virus type 1 (HIV-1) into cells is mediated by attachment of
the envelope glycoproteins, gp120 and gp41, to the CD4 receptor and a chemokine receptor …